Tetsuya Takao

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Journal: Cancer treatment and research communications
Published: March 26, 2026

Age-stratified trajectories of patient-reported outcomes and perioperative safety after robot-assisted radical prostatectomy: a prospective multicenter cohort study.

Age-stratified trajectories of patient-reported outcomes and perioperative safety after robot-assisted radical prostatectomy: a prospective multicenter cohort study.

Journal: Scientific reports
Published: February 13, 2026

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer.

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer.

Journal: BJUI compass
Published: January 06, 2026

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Journal: Scientific reports
Published: July 06, 2025

Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer.

Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer.

Journal: BMC urology
Published: May 08, 2025

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Journal: Anticancer research
Published: December 20, 2024

Comparative analysis of gut microbiota in hormone-sensitive and castration-resistant prostate cancer in Japanese men.

Comparative analysis of gut microbiota in hormone-sensitive and castration-resistant prostate cancer in Japanese men.

Journal: Cancer science
Published: September 03, 2024

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

Journal: International journal of clinical oncology
Published: June 23, 2024

EIF2S1 in Urinary Extracellular Vesicles as a Novel Diagnostic Marker for Bladder Cancer.

EIF2S1 in Urinary Extracellular Vesicles as a Novel Diagnostic Marker for Bladder Cancer.

Journal: Cancer medicine
Published: June 17, 2024

A Case of Metanephric Adenoma Treated with Robotic-Assisted Laparoscopic Partial Nephrectomy

A Case of Metanephric Adenoma Treated with Robotic-Assisted Laparoscopic Partial Nephrectomy

Journal: Hinyokika kiyo. Acta urologica Japonica
Published: January 10, 2024

Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.

Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.

Journal: Japanese journal of clinical oncology
Published: October 09, 2023

The Japanese Urological Association's clinical practice guidelines for urotrauma 2023.

The Japanese Urological Association's clinical practice guidelines for urotrauma 2023.

Journal: International journal of urology : official journal of the Japanese Urological Association
Published: August 30, 2023
Showing 1-12 of 87

Last Updated: 09/26/2026